Form 8-K - Current report:
SEC Accession No. 0001193125-24-045486
Filing Date
2024-02-26
Accepted
2024-02-26 09:04:31
Documents
15
Period of Report
2024-02-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d794479d8k.htm   iXBRL 8-K 25168
2 EX-99.1 d794479dex991.htm EX-99.1 13524
  Complete submission text file 0001193125-24-045486.txt   170555

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA akli-20240226.xsd EX-101.SCH 2877
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE akli-20240226_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akli-20240226_pre.xml EX-101.PRE 11725
17 EXTRACTED XBRL INSTANCE DOCUMENT d794479d8k_htm.xml XML 3794
Mailing Address 71 COMMERCIAL STREET MAILBOX 312 BOSTON MA 02109
Business Address 71 COMMERCIAL STREET MAILBOX 312 BOSTON MA 02109 617-456-0597
Akili, Inc. (Filer) CIK: 0001850266 (see all company filings)

IRS No.: 923654772 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40558 | Film No.: 24673784
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)